# Aortic Aneurysm Market

> Aortic Aneurysm Market Research Report By Type (Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, Cervical Aortic Aneurysm), By Diagnosis Method (Ultrasound, CT Scan, MRI, X-Ray, Angiography), By Treatment Type (Surgical Repair, Endovascular Aneurysm Repair, Medication, Monitoring), By End User (Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, Specialty Clinics) and By Regional (North America, Europe, South America, Asia-Pacific, Middle East and Africa) - Growth & Industry Forecast 2025 To 2035

- **Forecast Period:** 2025 - 2035
- **CAGR:** 5.39%
- **2024:** $ 6.37 Billion
- **2025:** $ 6.71 Billion
- **2035:** $ 11.34 Billion
- **Key Players:** Medtronic(US), Abbott Laboratories (US), Boston Scientific (US), Terumo Corporation (JP), Cook Medical (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cardinal Health (US), Stryker Corporation (US)

**Report ID:** MRFR/HC/6306-HCR · **Pages:** 90 · **Author:** Vikita Thakur & Rahul Gotadki · **Last Updated:** April 06, 2026

**URL:** https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776

---

## Market Summary

## **Global Aortic Aneurysm Market Overview**

As per MRFR analysis, the Aortic Aneurysm Market Size was estimated at 5.74 (USD Billion) in 2022. The Aortic Aneurysm Market Industry is expected to grow from 6.04(USD Billion) in 2023 to 9.7 (USD Billion) by 2032. The Aortic Aneurysm Market CAGR (growth rate) is expected to be around 5.39% during the forecast period (2024 - 2032).

## **Key Aortic Aneurysm Market Trends Highlighted**

Several key factors drive the Aortic Aneurysm Market. Increased prevalence of aortic aneurysms due to aging populations and lifestyle-related risk factors is a significant contributor. Advancements in treatment options, such as minimally invasive surgical techniques and innovative stent-grafts, are enhancing patient outcomes and driving market growth. Additionally, rising awareness about cardiovascular diseases and the importance of early diagnosis are encouraging more patients to seek medical intervention for aortic aneurysms.

The ongoing research and development efforts in healthcare technology are also playing a vital role in this market, providing sophisticated solutions to both patients and healthcare providers.There are many potential areas of development in the Aortic Aneurysm Market, especially in developing countries where the level of medical care is improving. Manufacturers could address their service penetration and improvement by entering into synergies with local healthcare providers. There is an increasing need for sophisticated devices as well as therapies that can be directed to neglected areas.

Moreover, the use of telemedicine is creating opportunities for follow-up and monitoring to take place, thus enabling the development of new business strategies that make relevant treatment more accessible to patients. Of late, it has become evident that there is a movement towards the idea of customized medicine in the treatment of aortic aneurysms.

Plans include more frequently manufacturing grafts and constructing treatment schedules relevant to every individual. Of particular interest to these countries is seeking improvement in medical devices, particularly in the area of biocompatible materials and smart technology. There is also growing interest in research partnerships and clinical studies that are likely to change the dynamics of the market. All in all, these market forces are stretching the limits of established practices in aortic aneurysms and management and heralding a move away from piecemeal interventions towards comprehensive shifts in the way healthcare is delivered.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

## **Aortic Aneurysm Market Drivers**

Increasing Prevalence of Aortic Aneurysm Conditions

The Aortic Aneurysm Market Industry is witnessing significant growth driven by the increasing prevalence of aortic aneurysm conditions around the world. Aortic aneurysms are defined as abnormal bulges in the wall of the aorta, the main artery that carries blood from the heart to the rest of the body. This condition can lead to serious health complications if not treated promptly. With lifestyle changes and an aging population globally, the incidence of aortic aneurysms is rising.Factors such as hypertension, high cholesterol levels, and diabetes are contributing to the growing number of at-risk patients.

As the awareness of vascular health increases and more patients are diagnosed early, there is a growing demand for advanced treatment options, clearly influencing the growth trajectory of the Aortic Aneurysm Market. Additionally, improved medical imaging technologies have resulted in better detection rates of aortic aneurysms, further propelling the need for effective treatment solutions.As healthcare providers emphasize early intervention to reduce mortality rates associated with untreated aneurysms, the demand for related devices and therapies is expected to rise. This trend foresees substantial market expansion, particularly in regions where healthcare infrastructure supports advanced medical interventions.

The increasing accessibility of diagnostics and treatment options for aortic aneurysms will thus contribute to the overall value of the Aortic Aneurysm Market in the coming years.

Technological Advancements in Treatment Options

Technological advancements play a prominent role in shaping the Aortic Aneurysm Market Industry. Ongoing innovations in surgical techniques, endovascular procedures, and medical devices are revolutionizing the treatment landscape for aortic aneurysms. Enhanced endovascular stent grafts, for example, are designed to minimize risks and improve patient outcomes significantly. Furthermore, the introduction of minimally invasive procedures is leading to quicker recovery times and reduced hospital stays.As these technologies continue to evolve, they provide healthcare providers with more precise tools for diagnosis and treatment, thereby increasing the overall efficiency and effectiveness of interventions for aortic aneurysms.

Such advancements are likely to contribute to the market growth and drive future investment in research and development in the Aortic Aneurysm Market.

Growing Awareness and Improved Healthcare Infrastructure

Growing awareness about cardiovascular health issues, including aortic aneurysms, is acting as a significant driver for the Aortic Aneurysm Market Industry. Health campaigns aimed at educating the population about the risk factors and symptoms of aortic aneurysms are crucial in facilitating early diagnosis and treatment. As more individuals understand the importance of vascular health, the rates of screening and proactive management are likely to increase.Additionally, improvements in healthcare infrastructure, particularly in emerging economies, are enabling better access to diagnostic tools and specialized treatment facilities.

As patients become more aware of their health conditions and the available medical resources, the demand for aortic aneurysm treatments is anticipated to grow, thus positively impacting market prospects.

## **Aortic Aneurysm Market Segment Insights**

### **Aortic Aneurysm Market Type Insights  **

The Aortic Aneurysm Market is expected to witness significant growth, driven by an increasing prevalence and awareness of aortic aneurysms and associated medical advancements. In 2023, the market is valued at 6.04 USD Billion, reflecting an expanding industry focused on treating various types of aortic aneurysms. In terms of market segmentation, the types are categorized into Thoracic Aortic Aneurysm, Abdominal Aortic Aneurysm, Thoracoabdominal Aortic Aneurysm, and Cervical Aortic Aneurysm, each presenting unique characteristics and significance within the market.

Among these, the Thoracic Aortic Aneurysm is a major contributor, valued at 2.42 USD Billion in 2023 and projected to grow to 3.78 USD Billion by 2032, demonstrating its dominance driven by rising surgical interventions and specialized care in thoracic regions. This segment is critical since thoracic aneurysms can arise from various conditions and often require complex management, thus ensuring a continuous demand for innovative treatment options. 

In conjunction, the Abdominal Aortic Aneurysm holds a notable valuation of 2.34 USD Billion in 2023, expected to reach 3.68 USD Billion by 2032. This segment's significance is underscored by the increasing need for screening and repairs, as abdominal aortic aneurysms are among the most prevalent forms affecting patients. Chronic conditions such as hypertension and smoking are major risk factors leading to this type of aneurysm, which makes the market for abdominal repairs crucial and responsive to preventive healthcare initiatives.

On the other hand, the Thoracoabdominal Aortic Aneurysm, valued at 0.88 USD Billion in 2023 with a projected increase to 1.38 USD Billion by 2032, accounts for a smaller but still significant portion of the market. This type of aneurysm represents a complex anatomical challenge due to its involvement of both thoracic and abdominal regions, making its management particularly important and specialized in nature.

Similarly, the Cervical Aortic Aneurysm, although valued at a modest 0.4 USD Billion in 2023 and anticipated to grow to 0.86 USD Billion by 2032, remains crucial for specific patient demographics, emphasizing the need for tailored therapeutic strategies.

Overall, the Aortic Aneurysm Market reveals an intricate tapestry of segments, each characterized by distinct clinical requirements and market drivers. The compelling statistics highlight the growing importance of increasingly sophisticated technologies and diagnostic methods to manage the various types effectively.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

### **Aortic Aneurysm Market Diagnosis Method Insights  **

The Aortic Aneurysm Market, with a focus on the Diagnosis Method segment, plays a crucial role in the early detection and management of this condition. In 2023, the market was valued at 6.04 USD Billion, reflecting the increasing awareness and advancements in diagnostic technologies. Various modalities, such as Ultrasound, CT Scan, MRI, X-ray, and Angiography, are employed for diagnosis. Ultrasound is favored for its non-invasive nature and real-time imaging capabilities, while CT Scans provide detailed cross-sectional views, essential for accurate diagnosis.MRI is significant for assessing soft tissue structures and thrombus within the aneurysm.

X-ray, though limited in detailed imaging, is often used for rapid assessment, while Angiography remains a standard for visualizing blood vessels, particularly in complex cases. The increasing prevalence of vascular diseases and technological innovations are driving the growth of this segment. However, challenges such as high costs and the requirement for skilled personnel pose barriers. Overall, the Aortic Aneurysm Market revenue reflects a trend towards improved diagnostic accuracy and patient outcomes, underlined by the continued evolution of imaging technologies in enhancing the clinical landscape.

### **Aortic Aneurysm Market Treatment Type Insights  **

The Aortic Aneurysm Market has shown significant growth, with the Treatment Type segment playing a vital role in this expansion. Surgical Repair is a prominent approach, known for addressing advanced cases effectively. Endovascular Aneurysm Repair has gained traction due to its minimally invasive nature, offering quicker recovery times, which makes it a preferred option among healthcare professionals. Medication also plays its part in managing aneurysms, focusing on controlling blood pressure and reducing risks, while Monitoring ensures ongoing assessment of patients at risk.Collectively, these treatment methods address varying patient needs, reflecting a comprehensive strategy for managing aortic aneurysms.

Advancements in technology shape the market dynamics, the increasing prevalence of cardiovascular diseases, and an aging population despite challenges such as surgical risks and healthcare costs. Overall, the Aortic Aneurysm Market revenue is projected to grow steadily as these treatment types continue to evolve, indicating promising opportunities in the industry.

### **Aortic Aneurysm Market End User Insights  **

The Aortic Aneurysm Market revenue is significantly driven by its End User category, which includes Hospitals, Ambulatory Surgical Centers, Diagnostic Laboratories, and Specialty Clinics. In 2023, the market was valued at 6.04 billion USD, showcasing robust growth dynamics. Hospitals continue to dominate this segment due to their comprehensive capabilities in surgical and diagnostic procedures, effectively addressing the needs of patients with aortic aneurysms.

Ambulatory Surgical Centers have gained traction as they provide efficient and cost-effective options for surgeries, appealing to both patients and healthcare providers.Diagnostic Laboratories play a crucial role by offering advanced imaging and testing services, vital for timely diagnosis and treatment planning. Specialty Clinics focusing on specific vascular diseases, are also a significant component by providing tailored treatment solutions. The increasing prevalence of aortic aneurysms and a growing elderly population act as catalysts for market growth, while advancements in medical technologies create opportunities for better patient outcomes, driving future developments in the Aortic Aneurysm Market industry.

### **Aortic Aneurysm Market Regional Insights  **

The Aortic Aneurysm Market revenue in 2023 reached 6.04 USD Billion, reflecting a diverse landscape across various regions. North America stands out with a market valuation of 2.38 USD Billion, demonstrating a majority holding and substantial demand for treatment options in vascular health, which significantly drives overall market growth. Europe follows with a notable valuation of 1.45 USD Billion, benefiting from advanced healthcare infrastructure and an increasing aging population.

The APAC region contributes with a valuation of 1.02 USD Billion, showcasing significant opportunities as the focus on healthcare accessibility expands.South America and the MEA regions hold relatively smaller shares at 0.41 USD Billion and 0.38 USD Billion, respectively, indicating growth potential due to rising awareness and healthcare initiatives aimed at addressing vascular disorders. The overall Aortic Aneurysm Market statistics highlight evolving dynamics, where the dominance of North America is influenced by research advancements and a higher prevalence of aortic aneurysms, while other regions are gradually catching up with increasing investments in healthcare technology and infrastructure upgrades.

Source: Primary Research, Secondary Research, _Market Research Future_ Database and Analyst Review

**Aortic Aneurysm Market Key Players and Competitive Insights:**

The Aortic Aneurysm Market is characterized by a landscape that features significant competition among various players who are actively involved in the development, manufacturing, and marketing of medical devices and therapies aimed at addressing aortic aneurysms. This market is driven by the increasing prevalence of aortic aneurysm diagnoses, leading to heightened demand for innovative treatment solutions that can effectively manage this serious medical condition. The competitive dynamics are shaped by factors such as technological advancements, product diversity, regulatory approvals, and the ongoing research and development efforts aimed at improving patient outcomes.

As the market evolves, companies are continually seeking strategic partnerships, enhancing product offerings, and expanding their geographical footprints to strengthen their market positions.Sutas has established a solid presence in the Aortic Aneurysm Market, leveraging its strengths in technological innovation and product quality. The company focuses on developing advanced devices that scope to improve the efficacy of aortic aneurysm treatments through minimally invasive techniques. Sutas is recognized for its commitment to research and development, ensuring its products remain at the forefront of medical technology by incorporating feedback from healthcare professionals and addressing the evolving needs of patients.

The firm also aims to enhance collaboration with clinical institutions, thereby improving the adoption of its innovative therapies. Sutas's emphasis on regulatory compliance and quality assurance contributes to its reputation, positioning the company as a trusted player within the marketplace.Cook Medical is another prominent entity in the Aortic Aneurysm Market, distinguishing itself through a robust portfolio of medical devices and treatments tailored for aortic aneurysms. The company's strength lies in its extensive experience and expertise in vascular intervention technologies. Cook Medical's products are designed to cater to a diverse range of clinical requirements, ultimately emphasizing patient safety and procedural effectiveness.

The organization has built a reputation for leveraging cutting-edge research and innovation to develop novel solutions that directly address aortic aneurysms. Additionally, Cook Medical's effective distribution channels and established relationships with healthcare providers bolster its market presence, facilitating wider access to its advanced therapeutic options. This strategic positioning enables Cook Medical to remain competitive in an evolving market landscape as it continually adapts to emerging trends and customer demands.

**Key Companies in the Aortic Aneurysm Market Include**

### Aortic Aneurysm Market Industry Developments

- **Q2 2024: Medtronic Receives FDA Approval for Latest Endurant II Stent Graft System for Abdominal Aortic Aneurysm Repair** Medtronic announced that the U.S. Food and Drug Administration (FDA) has approved its Endurant II Stent Graft System, designed for minimally invasive repair of abdominal aortic aneurysms, expanding its portfolio of endovascular solutions.
- **Q1 2024: Cook Medical Launches Zenith Alpha Thoracic Endovascular Graft in Europe** Cook Medical announced the commercial launch of its Zenith Alpha Thoracic Endovascular Graft in select European markets, providing a new option for the treatment of thoracic aortic aneurysms.
- **Q2 2024: Terumo Receives CE Mark for RelayPro Thoracic Stent-Graft System** Terumo announced it has received CE Mark approval for its RelayPro Thoracic Stent-Graft System, enabling commercialization in the European Union for the treatment of thoracic aortic aneurysms.
- **Q2 2024: Endologix Announces FDA Approval of ALTO Abdominal Stent Graft System** Endologix received FDA approval for its ALTO Abdominal Stent Graft System, a next-generation device for endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysms.
- **Q1 2024: Gore Receives FDA Approval for GORE EXCLUDER Conformable AAA Endoprosthesis** W.L. Gore & Associates announced FDA approval for its GORE EXCLUDER Conformable AAA Endoprosthesis, designed to treat abdominal aortic aneurysms with challenging anatomies.
- **Q2 2024: Medtronic Expands Aortic Portfolio with Acquisition of Aortica Corporation** Medtronic announced the acquisition of Aortica Corporation, a company specializing in personalized aortic repair solutions, to strengthen its position in the aortic aneurysm treatment market.
- **Q1 2024: MicroPort Scientific Receives NMPA Approval for Endovascular Aortic Repair Device in China** MicroPort Scientific announced that China's National Medical Products Administration (NMPA) has approved its endovascular aortic repair device for the treatment of abdominal aortic aneurysms.
- **Q2 2024: Terumo Opens New Manufacturing Facility for Aortic Stent Grafts in Ireland** Terumo Corporation inaugurated a new manufacturing facility in Ireland dedicated to the production of aortic stent grafts, aiming to meet growing global demand for endovascular aneurysm repair devices.
- **Q1 2024: Endologix Announces Strategic Partnership with Siemens Healthineers for Advanced Imaging in Aortic Procedures** Endologix entered into a partnership with Siemens Healthineers to integrate advanced imaging technologies into aortic aneurysm repair procedures, enhancing precision and patient outcomes.
- **Q2 2024: Cook Medical Receives FDA Breakthrough Device Designation for Fenestrated Endovascular Graft** Cook Medical announced that its new fenestrated endovascular graft for complex abdominal aortic aneurysms has received Breakthrough Device Designation from the FDA, expediting its path to market.
- **Q1 2024: Cardinal Health Appoints New Head of Vascular Solutions Division** Cardinal Health announced the appointment of a new executive to lead its Vascular Solutions Division, which includes its aortic aneurysm repair product line.
- **Q2 2024: Gore Launches New Clinical Trial for Next-Generation Thoracic Aortic Stent Graft** W.L. Gore & Associates initiated a new clinical trial to evaluate the safety and efficacy of its next-generation thoracic aortic stent graft in patients with thoracic aortic aneurysms.

## **Aortic Aneurysm Market Segmentation Insights**

### **Aortic Aneurysm Market Type Outlook**

### **Aortic Aneurysm Market Diagnosis Method Outlook**

### **Aortic Aneurysm Market Treatment Type Outlook**

### **Aortic Aneurysm Market End User Outlook**

### **Aortic Aneurysm Market Regional Outlook**

## Market Drivers

### Advancements in Surgical Techniques

Innovations in surgical techniques are significantly influencing the Aortic Aneurysm Market. Minimally invasive procedures, such as endovascular aneurysm repair (EVAR), have gained traction due to their reduced recovery times and lower complication rates compared to traditional open surgeries. The adoption of advanced imaging technologies and robotic-assisted surgeries is also enhancing the precision of these interventions. As a result, healthcare providers are increasingly opting for these modern techniques, which are expected to account for a substantial share of the market. Data suggests that the minimally invasive segment is projected to grow at a compound annual growth rate (CAGR) of over 10% in the coming years, reflecting the shift towards less invasive treatment options in the Aortic Aneurysm Market.

### Rising Incidence of Aortic Aneurysms

The increasing prevalence of aortic aneurysms is a notable driver in the Aortic Aneurysm Market. As populations age, the risk factors associated with aortic aneurysms, such as hypertension and atherosclerosis, become more pronounced. Recent data indicates that the incidence of aortic aneurysms has been steadily rising, with estimates suggesting that approximately 200,000 new cases are diagnosed annually. This growing patient population necessitates enhanced treatment options and monitoring solutions, thereby propelling the demand for innovative therapies and surgical interventions within the Aortic Aneurysm Market. Furthermore, the aging demographic is likely to contribute to a sustained increase in healthcare expenditures related to the management of aortic aneurysms, further stimulating market growth.

### Emerging Biologics and Pharmaceuticals

The development of new biologics and pharmaceuticals is emerging as a key driver in the Aortic Aneurysm Market. Research into targeted therapies and novel drug formulations is gaining momentum, with the potential to address the underlying causes of aortic aneurysms. These advancements may lead to more effective treatment options that not only manage symptoms but also modify disease progression. The market for pharmaceuticals related to aortic aneurysms is projected to witness substantial growth, as ongoing clinical trials and research initiatives yield promising results. Furthermore, collaborations between pharmaceutical companies and research institutions are likely to accelerate the introduction of innovative therapies, thereby enhancing the overall landscape of the Aortic Aneurysm Market.

### Increased Focus on Preventive Healthcare

The rising emphasis on preventive healthcare is shaping the Aortic Aneurysm Market. As awareness of cardiovascular health grows, more individuals are seeking regular screenings and check-ups to identify risk factors associated with aortic aneurysms. This trend is supported by public health campaigns and initiatives aimed at educating the population about the importance of early detection. Consequently, the demand for diagnostic imaging and monitoring devices is likely to rise, as healthcare providers prioritize preventive measures. Data indicates that the market for diagnostic tools related to aortic aneurysms is expected to expand significantly, driven by this shift towards preventive healthcare strategies. This proactive approach may ultimately lead to improved patient outcomes and reduced healthcare costs in the Aortic Aneurysm Market.

### Growing Investment in Healthcare Infrastructure

The expansion of healthcare infrastructure is a critical driver for the Aortic Aneurysm Market. Governments and private entities are investing heavily in healthcare facilities, particularly in regions with a high burden of cardiovascular diseases. This investment is aimed at improving access to diagnostic and treatment services for aortic aneurysms. Enhanced healthcare infrastructure facilitates the availability of advanced medical technologies and skilled professionals, which are essential for effective management of aortic aneurysms. As a result, the market is likely to experience growth as more patients gain access to timely and appropriate care. Furthermore, the establishment of specialized centers for vascular diseases is expected to bolster the Aortic Aneurysm Market by providing focused treatment options.

## Future Outlook

The Aortic Aneurysm Market is projected to grow at a 5.39% CAGR from 2025 to 2035, driven by technological advancements, increasing prevalence, and enhanced healthcare access.

**New opportunities:**

- Development of minimally invasive surgical devices for aortic repair. Expansion of telemedicine platforms for remote patient monitoring. Investment in AI-driven diagnostic tools for early aneurysm detection.

By 2035, the Aortic Aneurysm Market is expected to achieve substantial growth and innovation.

## Segment Insights

### By Type: Abdominal Aortic Aneurysm (Largest) vs. Thoracic Aortic Aneurysm (Fastest-Growing)

The Aortic Aneurysm Market is currently dominated by the [Abdominal Aortic Aneurysm](https://www.marketresearchfuture.com/reports/abdominal-aortic-aneurysm-market-30142) segment, which holds the largest share in terms of diagnosed cases and treatment procedures. Its prevalence among the aging population, coupled with risk factors such as hypertension and smoking, secures its position as a leader in the market. Conversely, the Thoracic Aortic Aneurysm segment has emerged as a significant player, growing rapidly due to increased awareness and advancements in surgical techniques that enhance patient outcomes. 

As healthcare facilities continue to improve diagnostic capabilities and treatment protocols, the market dynamics are shifting. The rising prevalence of thoracic aneurysms, alongside technological innovations in endovascular treatment, is propelling the growth of the Thoracic Aortic Aneurysm segment. Additionally, lifestyle changes and increased life expectancy contribute to the overall market growth, making it an attractive area for healthcare investment and research.

Abdominal Aortic Aneurysm (Dominant) vs. Thoracic Aortic Aneurysm (Emerging)

The Abdominal Aortic Aneurysm segment is characterized by a high prevalence rate among older adults, making it a focal point in the Aortic Aneurysm Market. This segment benefits from a well-established treatment framework comprising both surgical and endovascular options, which cater to diverse patient needs. On the other hand, the Thoracic Aortic Aneurysm segment is considered emerging due to its rapid growth spurred by advancements in minimally invasive surgical techniques. These innovations not only enhance safety and recovery times for patients but also broaden the scope of treatable cases. The combination of growing awareness, enhanced surgical options, and a supportive regulatory environment makes the Thoracic Aortic Aneurysm segment increasingly relevant in today's healthcare landscape.

### By Diagnosis Method: Ultrasound (Largest) vs. CT Scan (Fastest-Growing)

The Aortic Aneurysm Market features a diverse array of diagnosis methods, with Ultrasound commanding the largest market share due to its non-invasive nature and widespread accessibility. CT Scans follow closely behind, but they represent the fastest-growing segment, attributed to advancements in imaging technology that enhance diagnostic accuracy. MRI and X-Ray techniques hold smaller shares, emphasizing specialist applications, while Angiography is vital for detailed vascular insights but remains niche due to its invasive nature.

Ultrasound (Dominant) vs. CT Scan (Emerging)

Ultrasound technology has established itself as a dominant force in the Aortic Aneurysm Market diagnosis landscape. Its user-friendly interface and non-invasive procedure make it the go-to choice for preliminary assessments. In contrast, CT Scans, while previously considered secondary, are emerging with rapid advancements in imaging capability and speed. Their ability to furnish high-resolution images allows for more precise diagnostics, thereby highlighting critical aneurysm characteristics. The growth of CT Scan utilization is fueled by a rising demand for accurate diagnostics in an aging population, making the competition between these two modalities increasingly significant.

### By Treatment Type: Endovascular Aneurysm Repair (Largest) vs. Surgical Repair (Fastest-Growing)

In the Aortic Aneurysm Market, the distribution of treatment types indicates Endovascular Aneurysm Repair (EVAR) as the most prominent approach, taking significant market share due to its minimally invasive nature and quick recovery times. Meanwhile, Surgical Repair maintains a considerable share, driven by its effectiveness in certain high-risk patients. Medication and Monitoring are also key players, though they occupy smaller portions of the market as supportive therapies rather than primary treatment options.

Surgical Repair (Dominant) vs. Endovascular Aneurysm Repair (Emerging)

Surgical Repair has long been the standard treatment for aortic aneurysms, especially in patients with complex cases or those presenting in emergency situations. This method is viewed as highly reliable by healthcare providers, ensuring direct intervention and a definitive fix for the aneurysm. On the other hand, Endovascular Aneurysm Repair is gaining traction as an emerging treatment modality. As advances in technology make this less invasive technique more accessible, it appeals to a broader patient demographic seeking reduced recovery times and lower associated risks. The growing acceptance and precision of EVAR promise to shift treatment paradigms significantly in the coming years.

### By End User: Hospitals (Largest) vs. Ambulatory Surgical Centers (Fastest-Growing)

In the Aortic Aneurysm Market, hospitals account for the largest share of end user segments, driven by their capacity to provide comprehensive care and advanced surgical options. Given their well-equipped facilities and skilled medical professionals, hospitals are pivotal in diagnosing and treating aortic aneurysms, leading to their dominant position in the market. Conversely, ambulatory surgical centers (ASCs) are emerging rapidly, attracting a growing patient base due to their efficiency and cost-effectiveness for day surgeries. The shift towards outpatient procedures, patient preference for lower hospital stays, and advancements in surgical techniques are driving the expansion of ASCs in this market, showcasing them as the fastest-growing segment alongside traditional hospitals.

Hospitals (Dominant) vs. Ambulatory Surgical Centers (Emerging)

Hospitals serve as the cornerstone of the Aortic Aneurysm Market, offering a wide range of diagnostic and interventional procedures. Their dominance is attributed to specialized departments, access to advanced imaging technologies, and the ability to perform complex surgeries that require intricate follow-up care. As a result, hospitals remain the preferred choice for patients requiring comprehensive treatment and management of aortic aneurysms. On the other hand, ambulatory surgical centers (ASCs) are establishing themselves as a viable alternative, focusing on outpatient procedures for aortic aneurysms. ASCs prioritize patient comfort and affordability, boasting shorter wait times and lower costs than traditional hospitals. This side-by-side comparison highlights a dynamic shift where ASCs emerge as a significant player, addressing changing patient expectations towards healthcare delivery.

## Regional Market Share Analysis

The Aortic Aneurysm Market revenue in 2023 reached 6.04 USD Billion, reflecting a diverse landscape across various regions. North America stands out with a market valuation of 2.38 USD Billion, demonstrating a majority holding and substantial demand for treatment options in vascular health, which significantly drives overall market growth. Europe follows with a notable valuation of 1.45 USD Billion, benefiting from advanced healthcare infrastructure and an increasing aging population.

The APAC region contributes with a valuation of 1.02 USD Billion, showcasing significant opportunities as the focus on healthcare accessibility expands.South America and the MEA regions hold relatively smaller shares at 0.41 USD Billion and 0.38 USD Billion, respectively, indicating growth potential due to rising awareness and healthcare initiatives aimed at addressing vascular disorders. The overall Aortic Aneurysm Market statistics highlight evolving dynamics, where the dominance of North America is influenced by research advancements and a higher prevalence of aortic aneurysms, while other regions are gradually catching up with increasing investments in healthcare technology and infrastructure upgrades.

## Competitive Benchmarking

The Aortic Aneurysm Market is characterized by strong competition driven by innovation in minimally invasive devices, strengthening the aortic aneurysm repair devices market. Companies are actively enhancing their product portfolios to capture greater aortic aneurysm market share and expand their presence across abdominal and thoracic segments, including the thoracic aortic aneurysm market. This market is driven by the increasing prevalence of aortic aneurysm diagnoses, leading to heightened demand for innovative treatment solutions that can effectively manage this serious medical condition. The competitive dynamics are shaped by factors such as technological advancements, product diversity, regulatory approvals, and the ongoing research and development efforts aimed at improving patient outcomes. As the market evolves, companies are continually seeking strategic partnerships, enhancing product offerings, and expanding their geographical footprints to strengthen their market positions.Sutas has established a solid presence in the Aortic Aneurysm Market, leveraging its strengths in technological innovation and product quality. The company focuses on developing advanced devices that scope to improve the efficacy of aortic aneurysm treatments through minimally invasive techniques. Sutas is recognized for its commitment to research and development, ensuring its products remain at the forefront of medical technology by incorporating feedback from healthcare professionals and addressing the evolving needs of patients.
 
The firm also aims to enhance collaboration with clinical institutions, thereby improving the adoption of its innovative therapies. Sutas's emphasis on regulatory compliance and quality assurance contributes to its reputation, positioning the company as a trusted player within the marketplace.Cook Medical is another prominent entity in the Aortic Aneurysm Market, distinguishing itself through a robust portfolio of medical devices and treatments tailored for aortic aneurysms. The company's strength lies in its extensive experience and expertise in vascular intervention technologies. Cook Medical's products are designed to cater to a diverse range of clinical requirements, ultimately emphasizing patient safety and procedural effectiveness. The organization has built a reputation for leveraging cutting-edge research and innovation to develop novel solutions that directly address aortic aneurysms. Additionally, Cook Medical's effective distribution channels and established relationships with healthcare providers bolster its market presence, facilitating wider access to its advanced therapeutic options. This strategic positioning enables Cook Medical to remain competitive in an evolving market landscape as it continually adapts to emerging trends and customer demands.

## Recent News & Developments

- **Recent regulatory approvals and product launches across** abdominal and thoracic repair segments continue to accelerate innovation within the aortic aneurysm stent grafts market, the abdominal aortic aneurysm repair devices market, and the broader aortic aneurysm repair market, reinforcing sustained aortic aneurysm market growth.
- **Q2 2024: Medtronic Receives FDA Approval for Latest Endurant II Stent Graft System for Abdominal Aortic Aneurysm Market Repair** Medtronic announced that the U.S. Food and Drug Administration (FDA) has approved its Endurant II Stent Graft System, designed for minimally invasive repair of abdominal aortic aneurysms, expanding its portfolio of endovascular solutions.
- **Q1 2024: Cook Medical Launches Zenith Alpha Thoracic Endovascular Graft in Europe** Cook Medical announced the commercial launch of its Zenith Alpha Thoracic Endovascular Graft in select European markets, providing a new option for the treatment of thoracic aortic aneurysms.
- **Q2 2024: Terumo Receives CE Mark for RelayPro Thoracic Stent-Graft System** Terumo announced it has received CE Mark approval for its RelayPro Thoracic Stent-Graft System, enabling commercialization in the European Union for the treatment of thoracic aortic aneurysms.
- **Q2 2024: Endologix Announces FDA Approval of ALTO [Abdominal Stent Graft System](https://www.marketresearchfuture.com/reports/abdominal-stent-graft-system-market-34514)** Endologix received FDA approval for its ALTO Abdominal Stent Graft System, a next-generation device for endovascular aneurysm repair (EVAR) in patients with abdominal aortic aneurysms.
- **Q1 2024: Gore Receives FDA Approval for GORE EXCLUDER Conformable AAA Endoprosthesis** W.L. Gore & Associates announced FDA approval for its GORE EXCLUDER Conformable AAA Endoprosthesis, designed to treat abdominal aortic aneurysms with challenging anatomies.
- **Q2 2024: Medtronic Expands Aortic Portfolio with Acquisition of Aortica Corporation** Medtronic announced the acquisition of Aortica Corporation, a company specializing in personalized aortic repair solutions, to strengthen its position in the aortic aneurysm treatment market.
- **Q1 2024: MicroPort Scientific Receives NMPA Approval for Endovascular Aortic Repair Device in China** MicroPort Scientific announced that China's National Medical Products Administration (NMPA) has approved its endovascular aortic repair device for the treatment of abdominal aortic aneurysms.
- **Q2 2024: Terumo Opens New Manufacturing Facility for Aortic Stent Grafts in Ireland** Terumo Corporation inaugurated a new manufacturing facility in Ireland dedicated to the production of aortic stent grafts, aiming to meet growing global demand for endovascular aneurysm repair devices.
- **Q1 2024: Endologix Announces Strategic Partnership with Siemens Healthineers for Advanced Imaging in Aortic Procedures** Endologix entered into a partnership with Siemens Healthineers to integrate advanced imaging technologies into aortic aneurysm repair procedures, enhancing precision and patient outcomes.
- **Q2 2024: Cook Medical Receives FDA Breakthrough Device Designation for Fenestrated Endovascular Graft** Cook Medical announced that its new fenestrated endovascular graft for complex abdominal aortic aneurysms has received Breakthrough Device Designation from the FDA, expediting its path to market.
- **Q1 2024: Cardinal Health Appoints New Head of Vascular Solutions Division** Cardinal Health announced the appointment of a new executive to lead its Vascular Solutions Division, which includes its aortic aneurysm repair product line.
- **Q2 2024: Gore Launches New Clinical Trial for Next-Generation Thoracic Aortic Stent Graft** W.L. Gore & Associates initiated a new clinical trial to evaluate the safety and efficacy of its next-generation thoracic aortic stent graft in patients with thoracic aortic aneurysms.

## Report Scope

| MARKET SIZE 2024 | 6.366(USD Billion) |
| --- | --- |
| MARKET SIZE 2025 | 6.709(USD Billion) |
| MARKET SIZE 2035 | 11.34(USD Billion) |
| COMPOUND ANNUAL GROWTH RATE (CAGR) | 5.39% (2025 - 2035) |
| REPORT COVERAGE | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| BASE YEAR | 2024 |
| Market Forecast Period | 2025 - 2035 |
| Historical Data | 2019 - 2024 |
| Market Forecast Units | USD Billion |
| Key Companies Profiled | Medtronic (US), Abbott Laboratories (US), Boston Scientific (US), Terumo Corporation (JP), Cook Medical (US), Johnson & Johnson (US), B. Braun Melsungen AG (DE), Cardinal Health (US), Stryker Corporation (US) |
| Segments Covered | Type, Diagnosis Method, Treatment Type, End User, Regional |
| Key Market Opportunities | Advancements in minimally invasive surgical techniques enhance treatment options in the Aortic Aneurysm Market. |
| Key Market Dynamics | Technological advancements in minimally invasive procedures are reshaping treatment options in the Aortic Aneurysm Market. |
| Countries Covered | North America, Europe, APAC, South America, MEA |

## Frequently Asked Questions

**Q: What is the current valuation of the Aortic Aneurysm Market as of 2024?**
A: The Aortic Aneurysm Market was valued at 6.366 USD Billion in 2024.

**Q: What is the projected market valuation for the Aortic Aneurysm Market in 2035?**
A: The market is projected to reach 11.34 USD Billion by 2035.

**Q: What is the expected CAGR for the Aortic Aneurysm Market during the forecast period 2025 - 2035?**
A: The expected CAGR for the Aortic Aneurysm Market during 2025 - 2035 is 5.39%.

**Q: Which segment of the Aortic Aneurysm Market had the highest valuation in 2024?**
A: In 2024, the Abdominal Aortic Aneurysm segment had the highest valuation at 2.5 USD Billion.

**Q: What are the key players in the Aortic Aneurysm Market?**
A: Key players include Medtronic, Abbott Laboratories, Boston Scientific, and Johnson & Johnson.

**Q: How does the Thoracic Aortic Aneurysm segment perform in terms of valuation?**
A: The Thoracic Aortic Aneurysm segment was valued at 1.5 USD Billion in 2024 and is expected to grow.

**Q: What is the valuation range for Endovascular Aneurysm Repair from 2025 to 2035?**
A: The Endovascular Aneurysm Repair segment is projected to grow from 2.0 to 4.0 USD Billion during 2025 - 2035.

**Q: Which diagnostic method is expected to show significant growth in the Aortic Aneurysm Market?**
A: CT Scan, valued at 2.0 USD Billion in 2024, is expected to show significant growth.

**Q: What is the projected valuation for the Monitoring treatment type by 2035?**
A: The Monitoring treatment type is projected to reach 2.84 USD Billion by 2035.

**Q: Which end user segment is anticipated to dominate the Aortic Aneurysm Market?**
A: Hospitals, valued at 2.5 USD Billion in 2024, are anticipated to dominate the market.


---

*This Markdown endpoint is provided for AI systems and LLM crawlers. For the full interactive report visit https://www.marketresearchfuture.com/reports/aortic-aneurysm-market-7776*